QHSLab (QHSLab) Insider Ownership : 69.81 % (As of May. 27, 2024)

View and export this data going back to 1990. Start your Free Trial

What is QHSLab Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, QHSLab's insider ownership is 69.81%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, QHSLab's Institutional Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, QHSLab's Float Percentage Of Total Shares Outstanding is 62.28%.

QHSLab Insider Ownership Historical Data

The historical data trend for QHSLab's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QHSLab Insider Ownership Chart

QHSLab Historical Data

The historical data trend for QHSLab can be seen below:

	2009-06-30	2009-07-31	2009-08-31	2009-09-30	2009-10-31	2009-11-30	2009-12-31	2010-01-31	2010-02-28	2010-03-31
Insider Ownership	69.81	69.81	69.81	69.81	69.81	69.81	69.81	69.81	69.81	69.81

QHSLab Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

QHSLab (QHSLab) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » QHSLab Inc (OTCPK:USAQ) » Definitions » Insider Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

901 Northpoint Parkway, Suite 302, West Palm Beach, FL, USA, 33407

Website

https://www.qhslab.com

QHSLab Inc is a medical device company providing digital healthcare solutions and point-of-care-diagnostic tests to primary care physicians. It is a medical device technology and software as a service (SaaS) company focused on enabling primary care physicians (PCPs) to increase their revenues by providing them with relevant, value-based tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures.

Executives

Troy James Grogan	director, 10 percent owner, officer: CEO/Director	5480 N OCEAN DR B1D, SINGER ISLAND FL 33404
Richard J Rubin	director, 10 percent owner, officer: CEO & Chairman	90 JOHN STREET, SUITE 626, NEW YORK NY 10038